Article info
Short report
Non-fusion mutations in endometrial stromal sarcomas: what is the potential impact on tumourigenesis through cell cycle dysregulation?
- Correspondence to Dr Jennelle C Hodge, Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN 46202, USA; jhodge1{at}iu.edu
Citation
Non-fusion mutations in endometrial stromal sarcomas: what is the potential impact on tumourigenesis through cell cycle dysregulation?
Publication history
- Received February 4, 2020
- Revised March 30, 2020
- Accepted April 23, 2020
- First published May 8, 2020.
Online issue publication
January 24, 2021
Article Versions
- Previous version (23 November 2020).
- Previous version (23 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.